Molecular Mechanisms of Arterigenesis
Molecular Mechanisms of Arterigenesis
批准号:
10433814
负责人:
Michael Simons
金额:
$191.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-10 至 2024-10-31
关键词:
AffectAgeAnimalsAntibodiesAtherosclerosisAutomobile DrivingBiologicalBiologyBlood VesselsBlood capillariesBypassCardiologyCardiovascular DiseasesCellular biologyCerebrovascular DisordersCessation of lifeCholesterolComplexCoronary ArteriosclerosisDataDefectDeveloped CountriesDevelopmentDiseaseDisease modelEndothelial CellsEndotheliumEventExtracellular MatrixFutureGenesGoalsGrowthGrowth FactorGrowth and Development functionHumanImpairmentInflammatoryIntegrinsIschemiaKDR geneLaboratoriesLeadLiquid substanceMAPK1 geneMAPK3 geneMechanicsMediatingMicroRNAsMindModalityModelingMolecularMouse StrainsMyocardial InfarctionOxygenPathologyPathway interactionsPatientsPerfusionPeripheral arterial diseasePharmaceutical PreparationsPharmacologyPopulationPublic HealthReagentRecoveryRegulationResistanceRoleSignal PathwaySignal TransductionStentsTechnologyTestingTherapeuticTissuesVEGFA geneVascular Endothelial Growth FactorsVascular blood supplyagedangiogenesisbasebiomechanical engineeringdesignexperienceimprovedmultidisciplinarynext generation sequencingnovel therapeuticsprogramsresponserestorationshear stresstherapeutic angiogenesistherapeutically effectivetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall goal of this Program Project is to understand molecular mechanisms regulating
arteriogenesis that may be exploited as potential treatments for vasoocclusive cardiovascular
diseases including coronary artery disease, peripheral arterial disease and cerebrovascular
disease. We have assembled a multidisciplinary team of highly accomplished PIs with diverse
backgrounds (cardiology, cell biology, biomechanical engineering, pharmacology) to investigate
key molecular events that lead to development and growth of arterial vasculature. The in-depth
understanding of these mechanisms can then be parlayed into development of novel
therapeutic modalities for this important group of cardiovascular diseases. Together, our studies
will define the key events leading to arterial vessel growth and will lead to the development of
new therapies.
PPG Aims are:
Aim 1. Elucidate how ERK signaling controls arteriogenesis (Project 1).
Aim 2. Unravel the role of the miR 17-92 cluster in controlling arteriogenesis and its
regulation and interaction with ERK signaling (Project 2
Aim 3. Determine how fluid shear stress and changes in the extracellular matrix activate
ERKs and other signaling pathways that mediate arteriogenesis, and identify restriction
points that impair arteriogenesis in disease (Project 3).
Relevance to Public Health: Coronary artery disease and peripheral artery disease are major
causes of illness and death in developed nations. Poor arteriogenesis is a critical determinant of
these diseases and in patients’ recovery after myocardial infarction. This application proposes to
elucidate the signaling network that governs flow-dependent vessel remodeling and test two
new directions for improving arteriogenesis. These studies include testing whether activating an
arteriogenic signaling pathway improves arteriogenesis in disease models. They have the
potential to identify new targets and new reagents for therapy, as well as to achieve a deeper
understanding of the fundamental biology that will form the basis for future studies.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1161/atvbaha.114.303217
发表时间:
2014-09
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
[Zhang X, Simons M]
通讯作者:
Simons M
DOI:
10.1161/circulationaha.114.009683
发表时间:
2014-09-09
期刊:
Circulation
影响因子:
37.8
作者:
[Lanahan AA, Lech D, Dubrac A, Zhang J, Zhuang ZW, Eichmann A, Simons M]
通讯作者:
Simons M
DOI:
10.1016/j.bbagen.2014.01.013
发表时间:
2014-08
期刊:
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
影响因子:
3
作者:
[Calabro, Nicole E., Kristofik, Nina J., Kyriakides, Themis R.]
通讯作者:
Kyriakides, Themis R.
DOI:
10.1371/journal.pbio.1002148
发表时间:
2015-05
期刊:
PLoS biology
影响因子:
9.8
作者:
[Ricard N, Simons M]
通讯作者:
Simons M
DOI:
10.3389/fcell.2021.691335
发表时间:
2021
期刊:
Frontiers in cell and developmental biology
影响因子:
5.5
作者:
[Chen D, Schwartz MA, Simons M]
通讯作者:
Simons M
共 7 条
Ischemia/Reperfusion injury and Myocardial edema
-
批准号:10718260
-
项目类别:
-
资助金额:$61.03万
-
财政年份:2023
-
负责人:Michael Simons
-
依托单位:
Vascular smooth muscle cell heterogeneity and disease
-
批准号:10356855
-
项目类别:
-
资助金额:$83.06万
-
财政年份:2021
-
负责人:Michael Simons
-
依托单位:
Vascular smooth muscle cell heterogeneity and disease
-
批准号:10559596
-
项目类别:
-
资助金额:$83.11万
-
财政年份:2021
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:10192382
-
项目类别:
-
资助金额:$191.79万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
ERK signaling in arteriogenesis
-
批准号:10433818
-
项目类别:
-
资助金额:$56.25万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Administrative Core
-
批准号:10433815
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Administrative Core
-
批准号:10192383
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Raf 1-ERK cross-talk in Arteriogenesis
-
批准号:8250615
-
项目类别:
-
资助金额:$48.83万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8424224
-
项目类别:
-
资助金额:$180.54万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
ERK signaling in arteriogenesis
-
批准号:10192386
-
项目类别:
-
资助金额:$56.65万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8998042
-
项目类别:
-
资助金额:$187.49万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:9766884
-
项目类别:
-
资助金额:$191.39万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8607981
-
项目类别:
-
资助金额:$186.27万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
Molecular Mechanisms of Arterigenesis
-
批准号:8214772
-
项目类别:
-
资助金额:$185.71万
-
财政年份:2012
-
负责人:Michael Simons
-
依托单位:
2009 Vascular Biology Gordon Research Conference
-
批准号:7588171
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2009
-
负责人:Michael Simons
-
依托单位:
Yale Cardiovascular Center faculty recruitment
-
批准号:7859426
-
项目类别:
-
资助金额:$57.53万
-
财政年份:2009
-
负责人:Michael Simons
-
依托单位:
Yale Cardiovascular Center faculty recruitment
-
批准号:7937872
-
项目类别:
-
资助金额:$57.77万
-
财政年份:2009
-
负责人:Michael Simons
-
依托单位:
Arteriogenesis and arterial branching
-
批准号:7322580
-
项目类别:
-
资助金额:$50.67万
-
财政年份:2007
-
负责人:Michael Simons
-
依托单位:
Arteriogenesis and Arterial Branching
-
批准号:8470211
-
项目类别:
-
资助金额:$58.49万
-
财政年份:2007
-
负责人:Michael Simons
-
依托单位:
Arteriogenesis and arterial branching
-
批准号:7714236
-
项目类别:
-
资助金额:$34.06万
-
财政年份:2007
-
负责人:Michael Simons
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: